Serum prolidase activity and oxidative-antioxidative status in Legg-Calve-Perthes disease

Journal of Pediatric Orthopaedics Part B

Volumn 20, Issue 4, 2011, Pages 222-226

  Altay, Mehmet Akif ^a,b   Erturk, Cemil ^a   Aksoy, Nurten ^a   Taskin, Abdullah ^a   Bilge, Ali ^a   Celik, Hakim ^a   Isikan, Ugur Erdem ^a  

^a HARRAN UNIVERSITY   (Turkey)

^b Emniyet Caddesi Koc Apt No: 40/10 ^*  (Turkey)

Author keywords

collagen turnover; LeggCalvePerthes disease; oxidative stress; prolidase activity

Indexed keywords

PROLINE DIPEPTIDASE;

ARTICLE; BLOOD SAMPLING; CHILD; CLINICAL ARTICLE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; MALE; OXIDATIVE STRESS; PERTHES DISEASE; PRIORITY JOURNAL;

ANTIOXIDANTS; BIOLOGICAL MARKERS; CHILD; COLLAGEN; DIPEPTIDASES; FEMALE; HUMANS; LEGG-PERTHES DISEASE; MALE; OXIDATIVE STRESS;

EID: 79959253711     PISSN: 1060152X     EISSN: 14735865     Source Type: Journal    
DOI: 10.1097/BPB.0b013e32834493df     Document Type: Article

References (25)

1. Aksoy MC, Aksoy DY, Haznedaroglu IC, Sayinalp N, Kirazli S, Alpaslan M. Enhanced tissue factor pathway inhibitor response as a defense mechanism against ongoing local microvascular events of Legg-Calve-Perthes disease. Pediatr Hematol Oncol 2005; 22:391-399. (Pubitemid 40993602)
2. Herring JA. Tachdjians Pediatric Orthopaedics. Vol.1.3 rd. ed. Legg- Calve-Perthes Disease. Philadelphia: W.B.Saunders Company; 2002. pp. 655-709. Chapter 16.
3. Hofstaetter JG, Roschger P, Klaushofer K, Kim HK. Increased matrix mineralization in the immature femoral head following ischemic osteonecrosis. Bone 2010; 46:379-385.
4. Verit FF, Geyikli I, Yazgan P, Celik A. Correlations of serum prolidase activity between bone turnover markers and mineral density in postmenopausal osteoporosis. Arch Gynecol Obstet 2006; 274:133-137. (Pubitemid 43781417)
5. Lane N, Dequeker J, Mundy GR. Bone structure and function. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH. editors. Rheumatology Vol.1.4 nd.ed. Philadelphia, PA: Mosby-Elsevier; 2008. pp. 89-101.
6. Heinegard D, Lorenzo P, Saxne T. Articular cartilage. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH. Editors. Rheumatology Vol.1.4 nd.ed. Philadelphia, PA: Mosby-Elsevier; 2008. pp. 79-88.
7. Erbagci AB, Araz M, Erbagci A, Tarakcioglu M, Namiduru ES. Serum prolidase activity as a marker of osteoporosis in type 2 diabetes mellitus. Clin Biochem 2002; 35:263-268. (Pubitemid 34804895)
8. Lupi A, Rossi A, Vaghi P, Gallanti A, Cetta G. N-benzyloxycarbonyl-l- proline: an in vitro and in vivo inhibitor of prolidase. Biochim Biophys Acta 2005; 1744:157-163. (Pubitemid 40798923)
9. Palka JA, Phang JM. Prolidase activity in fibroblasts is regulated by interaction of extracellular matrix with cell surface integrin receptors. J Cell Biochem 1997; 67:166-175. (Pubitemid 27431161)
10. Altindag O, Erel O, Aksoy N, Selek S, Celik H, Karaoglanoglu M. Increased oxidative stress and its relation with collagen metabolism in knee osteoarthritis. Rheumatol Int 2007; 27:339-344. (Pubitemid 46122276)
11. Camuzcuoglu H, Arioz DT, Toy H, Kurt S, Celik H, Aksoy N. Assessment of preoperative serum prolidase activity in epithelial ovarian cancer. Eur J Obstet Gynecol Reprod Biol 2009; 147:97-100.
12. Yildiz A, Demirbag R, Yilmaz R, Gur M, Altiparmak IH, Akyol S, et al. The association of serum prolidase activity with the presence and severity of coronary artery disease. Coron Artery Dis 2008; 19:319-325.
13. Evrenkaya TR, Atasoyu EM, Kara M, Unver S, Gultepe M. The role of prolidase activity in the diagnosis of uremic bone disease. Ren Fail 2006; 28:271-274. (Pubitemid 43977335)
14. Gualicka A, Wolczyñski S, Anchim T, Surazyñski A, Lesniewicz R, Palka J. Defects of type I procollagen metabolism correlated with decrease of prolidase activity in a case of lethal osteogenesis imperfecta. Eur J Biochem 2001; 268:2172-2178. (Pubitemid 32852959)
15. Halliwell B, Gutteridge JMC. Free radicals in biology and medicine. 3rd ed. Oxford: Oxford Science Publications; 2000. pp. 617-624.
16. Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 2004; 37:112-119. (Pubitemid 38077161)
17. Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005; 38:1103-1111.
18. Martin JA, Brown TD, Heiner AD, Buckwalter JA. Chondrocyte senescence, joint loading and osteoarthritis. Clin Orthop Relat Res 2004; (427 Suppl):96-103.
19. Eckerwall G, Lohmander LS, Wingstrand H. Increased levels of proteoglycan fragments and stromelysin in hip joint fluid in Legg-Calvé- Perthes disease. J Pediatr Orthop 1997; 17:266-269. (Pubitemid 27118514)
20. Aslan M, Nazligul Y, Horoz M, Bolukbas C, Bolukbas FF, Aksoy N, et al. Serum prolidase activity and oxidative status in Helicobacter pylori infection. Clin Biochem 2007; 40:37-40. (Pubitemid 46014156)
21. Rabus M, Demirbag R, Yildiz A, Tezcan O, Yilmaz R, Ocak AR, et al. Association of prolidase activity, oxidative parameters, and presence of atrial fibrillation in patients with mitral stenosis. Arch Med Res 2008; 39:519-524.
22. Ozcan O, Gultepe M, Ipcioglu O, Bolat B, Kayadibi H. Optimization of the photometric enzyme activity assay for evaluating real activity of prolidase. Turk J Biochem 2007; 32:12-16.
23. Myara I, Charpentier C, Lemonnier A. Optimal conditions for prolidase assay by proline colorimetric determination: application to iminodipeptiduria. Clin Chim Acta 1982; 125:193-205. (Pubitemid 12002380)
24. Namiduru ES, Ozdemir Y, Kutlar I, Ersoy U. A study of prolidase in mothers, their newborn babies and in non-pregnant controls. Arch Gynecol Obstet 2001; 265:73-75. (Pubitemid 32494268)
25. Deberg M, Labasse A, Christgau S, Cloos P, Bang Henriksen D, Chapelle JP, et al. New serum biochemical markers (Coll 2-1 and Coll 2-1 NO2) for studying oxidative-related type II collagen network degradation in patients with osteoarthritis and rheumatoid arthritis. Osteoarthritis Cartilage 2005; 13:258-265. (Pubitemid 40277284)